Physician

Roy Edward Lehman, MD

According to 2025 Medicare claims, Roy Lehman, MD (NPI: 1124314067) practices ophthalmology in the Sherman-Denison, TX market, with the plurality of this provider's patient population coming from Grayson, TX. This provider's primary affiliated billing organization is RGB EYE ASSOCIATES,PA (NPI: 1508863994; TIN: 752645716) and primary practice location at 75090-2815.

Lehman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 902 traditional Medicare patients, billed 8,919 HCPCS/CPT codes, and received $743,473 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 2,541 prescription claims across 805 beneficiaries totaling $159,114 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 37 records totaling $490. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,160 to $743,473. Similarly, Part D prescription costs have risen steadily, from $5,374 to $159,114. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$420K$839K2015 Medicare payment: $3,160 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $134,541 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $650,764 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $681,793 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $839,350 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $797,398 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $799,296 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $699,546 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $735,839 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $743,473 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152943$3,160
20165041,101$134,541
20171,2394,455$650,764
20181,2794,605$681,793
20191,1394,739$839,350
20209234,355$797,398
20219694,462$799,296
20228744,001$699,546
20239047,924$735,839
20249028,919$743,473

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$264K$528K2015 Drug cost: $5,374 (USD; Tot_Drug_Cst)2016 Drug cost: $44,243 (USD; Tot_Drug_Cst)2017 Drug cost: $174,587 (USD; Tot_Drug_Cst)2018 Drug cost: $222,905 (USD; Tot_Drug_Cst)2019 Drug cost: $363,664 (USD; Tot_Drug_Cst)2020 Drug cost: $411,034 (USD; Tot_Drug_Cst)2021 Drug cost: $290,416 (USD; Tot_Drug_Cst)2022 Drug cost: $528,404 (USD; Tot_Drug_Cst)2023 Drug cost: $465,253 (USD; Tot_Drug_Cst)2024 Drug cost: $159,114 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154161$5,374
2016233595$44,243
20175411,598$174,587
20186542,091$222,905
20196682,208$363,664
20205752,023$411,034
20215471,803$290,416
20225701,750$528,404
20236612,175$465,253
20248052,541$159,114

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
66984Removal of cataract with insertion of prosthetic lens222387$356
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more152162$65
92012Established patient problem focused exam of visual system270391$60
92134Imaging of retina164232$28
92136Measurement of corneal curvature and depth of eye262640$18

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine361,305$25,523
Loteprednol EtabonateLoteprednol Etabonate1343,696$15,270
Prednisolone AcetatePrednisolone Acetate47612,234$14,538
XiidraLifitegrast17510$11,957
MieboPerfluorohexyloctane/Pf11468$11,137

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.37$490BIOTISSUE HOLDINGS INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Roy Edward Lehman, MD?

Tedicare shows public-source Medicare data for Roy Edward Lehman, MD (NPI 1124314067), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Roy Edward Lehman, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Roy Edward Lehman, MD?

Roy Edward Lehman, MD is linked to RGB EYE ASSOCIATES,PA (billing NPI 1508863994) in the available physician profile data.

Does Roy Edward Lehman, MD have Open Payments data?

Roy Edward Lehman, MD has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.